Shandong Luoxin Pharmaceutical Group Stock Co.,Ltd.

Shandong Luoxin Pharmaceutical Group, established in 2001, is a major modern enterprise group engaged in pharmaceutical research, development, production, trade, and healthcare services. The company has established pharmaceutical production and trade bases in Shandong, including the Luoxin Industry Park and the Hengxin Industry Park, consisting of multiple plants and sections, showcasing the rapid development of their healthcare industry. In line with its commitment to enhancing core competitiveness, the group founded Luoxin Biotechnology (Shanghai) Co., Ltd. in 2014 at the Zhangjiang High-Tech Park in Shanghai, serving as the research center for the company. This research center has assembled a team of more than 300 researchers, including staff with doctor and master's degrees, along with numerous overseas returnees, emphasizing a strong focus on talent development and attracting global expertise. The company has also established collaborations with prominent CRO companies domestically and intends to collaborate with major pharmaceutical groups in Europe and Asia. The establishment of the Shanghai Research Center has injected new vigor into the Luoxin Pharmaceutical Group, driving its efforts towards innovative and high-tech product development. With its facilities and research center strategically positioned, and a strong focus on talent acquisition and international collaborations, the group is poised for breakthroughs in the domestic and global healthcare and pharmaceutical arena.